Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/s42255-019-0134-8.

Title:
Metabolic Messengers: ceramides | Nature Metabolism
Description:
Ceramides are products of metabolism that accumulate in individuals with obesity or dyslipidaemia and alter cellular processes in response to fuel surplus. Their actions, when prolonged, elicit the tissue dysfunction that underlies diabetes and heart disease. Here, we review the history of research on these enigmatic molecules, exploring their discovery and mechanisms of action, the evolutionary pressures that have given them their unique attributes and the potential of ceramide-reduction therapies as treatments for cardiometabolic disease. Ceramides are bioactive lipids that regulate cellular signalling processes and metabolic pathways, and are implicated in various metabolic diseases. Here, Summers, Chaurasia and Holland provide a concise overview of the history of ceramides and their physiological roles, mechanisms of action and therapeutic potential.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {πŸ“š}

  • Education
  • Health & Fitness
  • Science

Content Management System {πŸ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {πŸ’°}


Display Ads {🎯}

$63,100 per month
Our calculations suggest that Nature.com earns between $42,042 and $115,616 monthly online from display advertisements.

Keywords {πŸ”}

pubmed, google, scholar, cas, ceramide, central, insulin, diabetes, resistance, nature, ceramides, plasma, cell, biol, metabolic, metab, disease, sphingolipids, fatty, inhibition, content, chem, muscle, metabolism, summers, access, article, liver, mice, synthesis, hepatic, lipid, atherosclerosis, skeletal, holland, heart, res, research, syndrome, human, novo, sphingolipid, biochem, sci, glucose, kinase, acid, patients, coronary, type,

Topics {βœ’οΈ}

nature portfolio journals permissions reprints nature portfolio privacy policy metabolic syndrome development obesity-induced cers6-dependent c16 org/2013meeting/abstracts/fulltext/f130122450 advertising diabetes research center author information authors social media diet-induced hamster model nature+ nature 544 nature lipid-induced insulin resistance research obesity-induced insulin resistance hepatic vldl-apob100 overproduction molecular lipid species author correspondence caveolin-enriched microdomains represents cholesterol/sphingolipid enriched microdomains fat-induced insulin resistance cers6-derived sphingolipids interact tumor necrosis factor-alpha fatty acid binding personal data reduced hepatic steatosis diet-induced obesity gut-liver axis hyperlipidemic apoe-deficient mice diet-induced steatohepatitis data protection obese insulin-resistant humans permissions springerlink instant access ceramide-induced autophagy ceramide-induced apoptosis apolipoprotein e-knockout mice higher ceramide content alter cellular processes chronic heart failure saturated fatty acids ceramide-reduction therapies metabolic messengers hepatic insulin resistance /2016/07/28/ceramides-plasma-a-test skeletal muscle triglycerides serine palmitoyltransferase overexpression

Questions {❓}

  • Ceramide-mediated apoptosis of hepatocytes in vivo: a matter of the nucleus?
  • Could ceramides become the new cholesterol?
  • Does this Schlank make me look fat?
  • PAQRs: a counteracting force to ceramides?
  • Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?
  • Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Metabolic Messengers: ceramides
         description:Ceramides are products of metabolism that accumulate in individuals with obesity or dyslipidaemia and alter cellular processes in response to fuel surplus. Their actions, when prolonged, elicit the tissue dysfunction that underlies diabetes and heart disease. Here, we review the history of research on these enigmatic molecules, exploring their discovery and mechanisms of action, the evolutionary pressures that have given them their unique attributes and the potential of ceramide-reduction therapies as treatments for cardiometabolic disease. Ceramides are bioactive lipids that regulate cellular signalling processes and metabolic pathways, and are implicated in various metabolic diseases. Here, Summers, Chaurasia and Holland provide a concise overview of the history of ceramides and their physiological roles, mechanisms of action and therapeutic potential.
         datePublished:2019-10-24T00:00:00Z
         dateModified:2019-10-24T00:00:00Z
         pageStart:1051
         pageEnd:1058
         sameAs:https://doi.org/10.1038/s42255-019-0134-8
         keywords:
            Cardiovascular diseases
            Mechanisms of disease
            Metabolic syndrome
            Sphingolipids
            Life Sciences
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42255-019-0134-8/MediaObjects/42255_2019_134_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42255-019-0134-8/MediaObjects/42255_2019_134_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42255-019-0134-8/MediaObjects/42255_2019_134_Fig3_HTML.png
         isPartOf:
            name:Nature Metabolism
            issn:
               2522-5812
            volumeNumber:1
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Scott A. Summers
               url:http://orcid.org/0000-0002-4919-0592
               affiliation:
                     name:University of Utah
                     address:
                        name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Bhagirath Chaurasia
               url:http://orcid.org/0000-0002-7998-9290
               affiliation:
                     name:University of Utah
                     address:
                        name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:William L. Holland
               affiliation:
                     name:University of Utah
                     address:
                        name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Metabolic Messengers: ceramides
      description:Ceramides are products of metabolism that accumulate in individuals with obesity or dyslipidaemia and alter cellular processes in response to fuel surplus. Their actions, when prolonged, elicit the tissue dysfunction that underlies diabetes and heart disease. Here, we review the history of research on these enigmatic molecules, exploring their discovery and mechanisms of action, the evolutionary pressures that have given them their unique attributes and the potential of ceramide-reduction therapies as treatments for cardiometabolic disease. Ceramides are bioactive lipids that regulate cellular signalling processes and metabolic pathways, and are implicated in various metabolic diseases. Here, Summers, Chaurasia and Holland provide a concise overview of the history of ceramides and their physiological roles, mechanisms of action and therapeutic potential.
      datePublished:2019-10-24T00:00:00Z
      dateModified:2019-10-24T00:00:00Z
      pageStart:1051
      pageEnd:1058
      sameAs:https://doi.org/10.1038/s42255-019-0134-8
      keywords:
         Cardiovascular diseases
         Mechanisms of disease
         Metabolic syndrome
         Sphingolipids
         Life Sciences
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42255-019-0134-8/MediaObjects/42255_2019_134_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42255-019-0134-8/MediaObjects/42255_2019_134_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs42255-019-0134-8/MediaObjects/42255_2019_134_Fig3_HTML.png
      isPartOf:
         name:Nature Metabolism
         issn:
            2522-5812
         volumeNumber:1
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Scott A. Summers
            url:http://orcid.org/0000-0002-4919-0592
            affiliation:
                  name:University of Utah
                  address:
                     name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Bhagirath Chaurasia
            url:http://orcid.org/0000-0002-7998-9290
            affiliation:
                  name:University of Utah
                  address:
                     name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:William L. Holland
            affiliation:
                  name:University of Utah
                  address:
                     name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Metabolism
      issn:
         2522-5812
      volumeNumber:1
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Utah
      address:
         name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
         type:PostalAddress
      name:University of Utah
      address:
         name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
         type:PostalAddress
      name:University of Utah
      address:
         name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Scott A. Summers
      url:http://orcid.org/0000-0002-4919-0592
      affiliation:
            name:University of Utah
            address:
               name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Bhagirath Chaurasia
      url:http://orcid.org/0000-0002-7998-9290
      affiliation:
            name:University of Utah
            address:
               name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
               type:PostalAddress
            type:Organization
      name:William L. Holland
      affiliation:
            name:University of Utah
            address:
               name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
      name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
      name:Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Center, University of Utah, Salt Lake City, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {πŸ‘}(1)

External Links {πŸ”—}(307)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {πŸ“¦}

  • Crossref

4.63s.